AsianInvesterAsianInvesterAsianInvester

Asian family offices, endowments take closer look at biotech

Indira Vergis
Biotech funding has improved this year but remains well below the post-pandemic boom. Still, picking winners in the sector requires deep knowledge and investor discipline.
Asian family offices, endowments take closer look at biotech

Interest in biotechnology among Asian family offices and other institutional investors is improving as funding starts to pick up and interest rates come down, setting the stage for a sector revival.

Sign in to read on!
Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to AsianInvestor

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a senior professional at a large institutional asset owner, such as a sovereign wealth fund or pension fund, please contact [email protected] for further assistance.

Questions?
See here for more information on licences and prices, or contact [email protected]
¬ Haymarket Media Limited. All rights reserved.